These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 22172034)

  • 21. Inhibition of osteoclast function by adenovirus expressing antisense protein-tyrosine kinase 2.
    Duong LT; Nakamura I; Lakkakorpi PT; Lipfert L; Bett AJ; Rodan GA
    J Biol Chem; 2001 Mar; 276(10):7484-92. PubMed ID: 11102447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dasatinib as a bone-modifying agent: anabolic and anti-resorptive effects.
    Garcia-Gomez A; Ocio EM; Crusoe E; Santamaria C; Hernández-Campo P; Blanco JF; Sanchez-Guijo FM; Hernández-Iglesias T; Briñón JG; Fisac-Herrero RM; Lee FY; Pandiella A; San Miguel JF; Garayoa M
    PLoS One; 2012; 7(4):e34914. PubMed ID: 22539950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Osteoclast motility: putting the brakes on bone resorption.
    Novack DV; Faccio R
    Ageing Res Rev; 2011 Jan; 10(1):54-61. PubMed ID: 19788940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Syk tyrosine 317 negatively regulates osteoclast function via the ubiquitin-protein isopeptide ligase activity of Cbl.
    Zou W; Reeve JL; Zhao H; Ross FP; Teitelbaum SL
    J Biol Chem; 2009 Jul; 284(28):18833-9. PubMed ID: 19419964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of sealing ring formation by L-plastin and cortactin in osteoclasts.
    Ma T; Sadashivaiah K; Madayiputhiya N; Chellaiah MA
    J Biol Chem; 2010 Sep; 285(39):29911-24. PubMed ID: 20650888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rac-GTPase, osteoclast cytoskeleton and bone resorption.
    Razzouk S; Lieberherr M; Cournot G
    Eur J Cell Biol; 1999 Apr; 78(4):249-55. PubMed ID: 10350213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Localization and possible role of two different alpha v beta 3 integrin conformations in resting and resorbing osteoclasts.
    Faccio R; Grano M; Colucci S; Villa A; Giannelli G; Quaranta V; Zallone A
    J Cell Sci; 2002 Jul; 115(Pt 14):2919-29. PubMed ID: 12082152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Src kinase activity is essential for osteoclast function.
    Miyazaki T; Sanjay A; Neff L; Tanaka S; Horne WC; Baron R
    J Biol Chem; 2004 Apr; 279(17):17660-6. PubMed ID: 14739300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autophagy proteins regulate the secretory component of osteoclastic bone resorption.
    DeSelm CJ; Miller BC; Zou W; Beatty WL; van Meel E; Takahata Y; Klumperman J; Tooze SA; Teitelbaum SL; Virgin HW
    Dev Cell; 2011 Nov; 21(5):966-74. PubMed ID: 22055344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absence of Dap12 and the αvβ3 integrin causes severe osteopetrosis.
    Zou W; Teitelbaum SL
    J Cell Biol; 2015 Jan; 208(1):125-36. PubMed ID: 25547154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of osteoclast differentiation and bone resorption by Rho GTPases.
    Touaitahuata H; Blangy A; Vives V
    Small GTPases; 2014; 5():e28119. PubMed ID: 24614674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How do bone cells secrete proteins?
    Zhao H; Ito Y; Chappel J; Andrews N; Ross FP; Teitelbaum SL
    Adv Exp Med Biol; 2010; 658():105-9. PubMed ID: 19950020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of c-Src in cellular events associated with colony-stimulating factor-1-induced spreading in osteoclasts.
    Insogna K; Tanaka S; Neff L; Horne W; Levy J; Baron R
    Mol Reprod Dev; 1997 Jan; 46(1):104-8. PubMed ID: 8981371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A dual-specific macrophage colony-stimulating factor antagonist of c-FMS and αvβ3 integrin for osteoporosis therapy.
    Zur Y; Rosenfeld L; Keshelman CA; Dalal N; Guterman-Ram G; Orenbuch A; Einav Y; Levaot N; Papo N
    PLoS Biol; 2018 Aug; 16(8):e2002979. PubMed ID: 30142160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel small-molecule PPI inhibitor targeting integrin αvβ3-osteopontin interface blocks bone resorption in vitro and prevents bone loss in mice.
    Park D; Park CW; Choi Y; Lin J; Seo DH; Kim HS; Lee SY; Kang IC
    Biomaterials; 2016 Aug; 98():131-42. PubMed ID: 27187277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrin-mediated signaling in the regulation of osteoclast adhesion and activation.
    Duong LT; Rodan GA
    Front Biosci; 1998 Aug; 3():d757-68. PubMed ID: 9682033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Convergence of alpha(v)beta(3) integrin- and macrophage colony stimulating factor-mediated signals on phospholipase Cgamma in prefusion osteoclasts.
    Nakamura I; Lipfert L; Rodan GA; Le T Duong
    J Cell Biol; 2001 Jan; 152(2):361-73. PubMed ID: 11266452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adapters in lymphocyte signaling.
    Leo A; Wienands J; Baier G; Horejsi V; Schraven B
    J Clin Invest; 2002 Feb; 109(3):301-9. PubMed ID: 11827988
    [No Abstract]   [Full Text] [Related]  

  • 39. Coordinate interactions of Csk, Src, and Syk kinases with [alpha]IIb[beta]3 initiate integrin signaling to the cytoskeleton.
    Obergfell A; Eto K; Mocsai A; Buensuceso C; Moores SL; Brugge JS; Lowell CA; Shattil SJ
    J Cell Biol; 2002 Apr; 157(2):265-75. PubMed ID: 11940607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. V-ATPase subunit ATP6AP1 (Ac45) regulates osteoclast differentiation, extracellular acidification, lysosomal trafficking, and protease exocytosis in osteoclast-mediated bone resorption.
    Yang DQ; Feng S; Chen W; Zhao H; Paulson C; Li YP
    J Bone Miner Res; 2012 Aug; 27(8):1695-707. PubMed ID: 22467241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.